CollPlant Biotechnologies (CLGN) Depreciation and Depletion (2019 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Depreciation and Depletion came in at $224000.0 in Q4 2021, up 34.94% YoY from $166000.0 in Q4 2020, and up 13.71% on a QoQ basis from $197000.0 in Q3 2021.
CollPlant Biotechnologies (CLGN) Depreciation and Depletion (2019 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 3 years of Depreciation and Depletion data on file, last reported at $224000.0 in Q4 2021.
- Quarterly Depreciation and Depletion rose 34.94% year-over-year to $224000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $754000.0 (up 14.24% YoY) and the FY2025 annual result came in at $854000.0, down 12.95% from the prior year.
- Depreciation and Depletion advanced to $224000.0 in Q4 2021, from $197000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $224000.0 in Q4 2021 to a low of $97000.0 in Q1 2019.
- A 3-year average of $162000.0 and a median of $165000.0 in 2020 frame the typical range for Depreciation and Depletion.
- The widest YoY moves for Depreciation and Depletion: up 69.07% in 2020, down 1.78% in 2020.
- Tracing CLGN's Depreciation and Depletion over 3 years: stood at $169000.0 in 2019, then fell by 1.78% to $166000.0 in 2020, then surged by 34.94% to $224000.0 in 2021.
- The last three Depreciation and Depletion figures came in at $224000.0 (Q4 2021), $197000.0 (Q3 2021), and $166000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 224,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 197,000.00 |
| Sep 30, 2021 | 197,000.00 |
| Dec 31, 2020 | 166,000.00 |
| Dec 31, 2020 | 166,000.00 |
| Sep 30, 2020 | 167,000.00 |
| Sep 30, 2020 | 167,000.00 |
| Jun 30, 2020 | 163,000.00 |
| Jun 30, 2020 | 163,000.00 |
| Mar 31, 2020 | 164,000.00 |
| Mar 31, 2020 | 164,000.00 |
| Dec 31, 2019 | 169,000.00 |
| Dec 31, 2019 | 169,000.00 |
| Sep 30, 2019 | 142,000.00 |
| Sep 30, 2019 | 142,000.00 |
| Jun 30, 2019 | 131,000.00 |
| Jun 30, 2019 | 131,000.00 |
| Mar 31, 2019 | 97,000.00 |
| Mar 31, 2019 | 97,000.00 |